Amneal Invests Up To $200m In Manufacturing Under Metsera GLP-1 Pact
Collaboration Follows ‘Highly Competitive’ Phase I Data For Metsera Asset
Amneal will lend its expertise in product development and manufacturing under a collaboration with obesity and metabolic disorders start-up Metsera – the latest in a recent string of deals involving the highly sought-after GLP-1 analogs.
